Figure 4From: Extent of liver inflammation in predicting response to interferon α & Ribavirin in chronic hepatitis C patients: a cohort study ROC curve for validity of pretreatment ALT for mild vs. minimal inflammation. Part ‘a’ shows AUROC of pre-treatment ALT for mild compared to minimal liver inflammation in males, having a value of 0.629. Part ‘b’ shows AUROC of pre-treatment ALT for mild compared to minimal liver inflammation in females, a value of 0.638. Pre-treatment ALT is less accurate in measuring mild as compared to minimal inflammation in both genders.Back to article page